tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Compare Virax Biolabs Group Ltd. Class A (VRAX) vs. Competitors

Compare
124 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Virax Biolabs Group Ltd. Class A
$0.31
$2.27M
-0.24
-85.70%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biodexa Pharmaceuticals
$2.33
$1.39M
-0.03
-94.84%
Scinai Immunotherapeutics
$0.78
$737.84K
-0.07
-75.74%
Aditxt
$0.87
$486.72K
-99.98%
Dermata Therapeutics
$2.14
$2.36M
-0.11
-82.71%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRAX
Virax Biolabs Group Ltd. Class A
0.31
-1.78
-85.36%
BDRX
Biodexa Pharmaceuticals
2.24
-41.76
-94.91%
SCNI
Scinai Immunotherapeutics
0.87
-2.70
-75.70%
CLSD
ADTX
Aditxt
0.87
-3,714.01
-99.98%
DRMA
Dermata Therapeutics
2.30
-10.40
-81.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts